RFL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 32.90%

Insider Buying (Last 12 Months): $16,742,984.96

Insider Selling (Last 12 Months): $0.00

Rafael Insider Trading History Chart

Rafael Share Price & Price History

^$1.24

▼ -0.015 (-1.20%)

As of 12/4/2025 04:59 PM ET

Days: 30 | 90 | 365

Rafael Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/5/2025	Howard S. Jonas	CEO	Buy	13,080,457	$1.28	$16,742,984.96	12,299,207

SEC Filings (Institutional Ownership Changes) for Rafael (NYSE:RFL)

11.30% of Rafael stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Rafael Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Citadel Advisors LLC	72,584	$99K	0.0%	+132.3%	0.140%
11/12/2025	Dimensional Fund Advisors LP	298,227	$0.41M	0.0%	-11.5%	0.576%
11/7/2025	Vanguard Group Inc.	1,394,726	$1.90M	0.0%	+10.5%	3.975%
8/14/2025	Cable Car Capital LP	100,000	$0.17M	0.0%	N/A	0.285%
8/13/2025	Marshall Wace LLP	28,700	$50K	0.0%	N/A	0.082%
8/8/2025	Geode Capital Management LLC	451,139	$0.78M	0.0%	+72.9%	1.286%
8/7/2025	Americana Partners LLC	43,793	$76K	0.0%	N/A	0.125%
8/5/2025	Simplex Trading LLC	18,742	$32K	0.0%	N/A	0.053%
5/14/2025	Ieq Capital LLC	238,878	$0.45M	0.0%	N/A	0.959%
4/16/2025	Wealth Enhancement Advisory Services LLC	13,695	$26K	0.0%	N/A	0.055%
2/17/2025	Kahn Brothers Group Inc.	167,461	$0.28M	0.1%	-37.4%	0.679%
2/12/2025	Geode Capital Management LLC	174,561	$0.29M	0.0%	+17.9%	0.707%
1/29/2025	Peapod Lane Capital LLC	335,219	$0.55M	0.5%	N/A	1.359%
11/16/2024	Geode Capital Management LLC	148,068	$0.29M	0.0%	+24.8%	0.603%
8/9/2024	Old West Investment Management LLC	101,732	$0.15M	0.1%	+102.0%	0.414%
8/9/2024	Renaissance Technologies LLC	66,290	$95K	0.0%	-32.2%	0.270%
5/7/2024	Marquette Asset Management LLC	49,256	$85K	0.0%	N/A	0.200%
2/2/2024	Acuitas Investments LLC	322,372	$0.59M	0.3%	+38.1%	1.315%
8/10/2023	Meitav Investment House Ltd.	27,000	$0.52M	0.0%	N/A	0.111%
8/9/2023	Kahn Brothers Group Inc.	275,236	$0.58M	0.1%	-1.5%	1.133%
7/24/2023	Meitav Investment House Ltd.	27,000	$0.52M	0.0%	N/A	0.111%
5/8/2023	Old West Investment Management LLC	50,703	$79K	0.0%	-18.3%	0.209%
5/3/2023	Integrated Wealth Concepts LLC	25,116	$39K	0.0%	N/A	0.103%
2/14/2023	Susquehanna International Group LLP	14,095	$26K	0.0%	+176.4%	0.058%
2/10/2023	New York Life Investment Management LLC	225,990	$0.42M	0.0%	+12.7%	0.924%
11/10/2022	Nantahala Capital Management LLC	72,678	$0.13M	0.0%	+274.0%	0.349%
11/2/2022	Aptus Capital Advisors LLC	19,616	$35K	0.0%	N/A	0.094%
8/15/2022	Nantahala Capital Management LLC	19,435	$36K	0.0%	N/A	0.093%
7/27/2022	Advisor Resource Council	27,712	$52K	0.0%	N/A	0.133%
7/15/2022	Marquette Asset Management LLC	49,256	$92K	0.0%	N/A	0.237%
7/13/2022	Private Advisor Group LLC	13,403	$25K	0.0%	N/A	0.064%
5/17/2022	Empery Asset Management LP	11,983	$30K	0.1%	-85.0%	0.058%
5/17/2022	Great Point Partners LLC	121,000	$0.30M	0.1%	-57.6%	0.582%
5/16/2022	Deep Track Capital LP	104,156	$0.26M	0.0%	-63.5%	0.501%
5/16/2022	J. Goldman & Co LP	783,156	$1.97M	0.1%	+14.3%	3.764%
5/6/2022	IndexIQ Advisors LLC	146,100	$0.37M	0.0%	N/A	0.702%
5/5/2022	Fisher Asset Management LLC	22,000	$55K	0.0%	N/A	0.106%
2/14/2022	PDT Partners LLC	23,001	$0.12M	0.0%	N/A	0.111%
2/14/2022	Deep Track Capital LP	285,714	$1.46M	0.1%	N/A	1.380%
2/14/2022	Cadian Capital Management LP	285,714	$1.46M	0.1%	-25.2%	1.380%
2/10/2022	Old West Investment Management LLC	428,881	$2.19M	1.1%	-32.2%	2.072%
2/9/2022	Dimensional Fund Advisors LP	609,939	$3.11M	0.0%	-13.0%	2.947%
2/8/2022	Northern Trust Corp	110,447	$0.56M	0.0%	-2.4%	0.534%
1/28/2022	Allspring Global Investments Holdings LLC	11,307	$57K	0.0%	N/A	0.055%
1/25/2022	Kahn Brothers Group Inc. DE	283,007	$1.44M	0.2%	-9.2%	1.367%
11/17/2021	Park West Asset Management LLC	1,978,250	$60.79M	1.4%	N/A	9.575%
11/16/2021	Squarepoint Ops LLC	6,619	$0.20M	0.0%	N/A	0.032%
11/16/2021	Two Sigma Investments LP	20,597	$0.63M	0.0%	N/A	0.100%
11/15/2021	Great Point Partners LLC	285,714	$8.78M	2.0%	N/A	1.383%
11/15/2021	Dimensional Fund Advisors LP	701,482	$21.56M	0.0%	-5.6%	3.395%
11/12/2021	Renaissance Technologies LLC	245,831	$7.55M	0.0%	-15.0%	1.190%
11/12/2021	PEAK6 Investments LLC	8,404	$0.26M	0.0%	N/A	0.041%
11/10/2021	Goldman Sachs Group Inc.	195,113	$6M	0.0%	+1,131.7%	0.944%
11/9/2021	BlackRock Inc.	611,993	$18.81M	0.0%	-2.3%	2.962%
11/4/2021	Deutsche Bank AG	46,301	$1.42M	0.0%	+13.4%	0.224%
11/3/2021	Dupont Capital Management Corp	9,600	$0.30M	0.0%	N/A	0.046%
11/1/2021	SG Americas Securities LLC	5,020	$0.15M	0.0%	N/A	0.024%
10/28/2021	Signaturefd LLC	6,953	$0.21M	0.0%	N/A	0.034%
10/26/2021	Old West Investment Management LLC	632,851	$19.45M	5.1%	+0.2%	3.063%
10/21/2021	Kestra Private Wealth Services LLC	50,000	$1.54M	0.1%	N/A	0.282%
10/21/2021	SkyOak Wealth LLC	84,500	$2.60M	0.7%	N/A	0.477%
8/17/2021	Millennium Management LLC	17,210	$0.88M	0.0%	-35.0%	0.097%

Data available starting January 2016

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

Today's Range

Now: $1.24

$1.22

$1.26

50 Day Range

MA: $1.31

$1.18

$1.39

52 Week Range

Now: $1.24

$1.17

$3.19

Volume

36,250 shs

Average Volume

96,520 shs

Market Capitalization

$63.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Rafael?: Rafael's top insider investors include:
Howard S Jonas (CEO)
Learn More about top insider investors at Rafael.
Who are the major institutional investors of Rafael?: Rafael's top institutional shareholders include:
Vanguard Group Inc. — 3.97%
Dimensional Fund Advisors LP — 0.58%
Citadel Advisors LLC — 0.14%
Learn More about top institutional investors of Rafael stock.
Which major investors are selling Rafael stock?: During the last quarter, RFL stock was sold by these institutional investors:
Dimensional Fund Advisors LP
Which major investors are buying Rafael stock?: Within the last quarter, RFL stock was acquired by institutional investors including:
Vanguard Group Inc.
Citadel Advisors LLC